Clinical Trials · NCT04881760
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 338
- Start date
- May 2021
- Locations
- 28 sites, United States, Puerto Rico
- Primary endpoint
- Mean Percent Change From Baseline in Body Weight